BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1658502)

  • 1. [Anti-HCV-screening of blood donors in Gothenburg--the second generation tests are more specific].
    Lindholm A; Shev S; Norkrans G; Iwarson S; Hermodsson S
    Lakartidningen; 1991 Oct; 88(42):3475-6. PubMed ID: 1658502
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reactivity of hepatitis C virus (HCV) antibody among blood donors in Hungary].
    Héjjas M; Medgyesi G; Hajnal A
    Orv Hetil; 1992 Jul; 133 Suppl 1():21-4. PubMed ID: 1321394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serological study on hepatitis C (HCV) in 4371 blood donors].
    Arnone M; Pinducciu G; Usai M; Pitzus F; Pintus L
    Ann Ig; 1990; 2(5):353-8. PubMed ID: 1715726
    [No Abstract]   [Full Text] [Related]  

  • 4. [HCV antibodies in selected patient groups and blood donors].
    Courault K; Lisse C; Ehrenberg M; Stolle K; Brandstädter W; Fritzsche L
    Beitr Infusionsther; 1991; 28():22-4. PubMed ID: 1725624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test.
    Serfaty L; Nousbaum JB; Elghouzzi MH; Giral P; Legendre C; Poupon R
    Hepatology; 1995 Mar; 21(3):725-9. PubMed ID: 7875670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
    Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of screening and complementary tests for anti-HCV antibodies].
    Głoskowska-Moraczewska Z; Kacperska E; Seyfried H
    Acta Haematol Pol; 1993; 24(3):273-80. PubMed ID: 7504386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second generation anti-HCV test: seroprevalence in hemodialysis patients and blood donors.
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Transplant Proc; 1992 Dec; 24(6):2648-9. PubMed ID: 1334595
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ALAT and viral RNA as risk factors in 68 blood donors with anti-hepatitis C antibodies].
    Tullen E; De Saussure P; Soulier-Lauper M
    Schweiz Med Wochenschr; 1993 Jan; 123(3):57-61. PubMed ID: 7678939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of ALT increase in blood donors with antiviral antibodies of hepatitis C with negative first generation ELISA].
    Suárez A; Navascues CA; Rodríguez M; Rodrigo L
    Med Clin (Barc); 1992 Jun; 99(5):198-9. PubMed ID: 1324384
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey.
    Serfaty L; Giral P; Elghouzzi MH; Jullien AM; Poupon R
    Hepatology; 1993 Feb; 17(2):183-7. PubMed ID: 8381381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis C virus antibody in the serum of blood donors].
    Barna TK; Ozsvár Z; Szendrényi V; Gál G
    Orv Hetil; 1996 Mar; 137(10):507-11. PubMed ID: 8713664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of hepatitis C virus antibodies and elevated serum alanine transaminase levels in Ghanaian blood donors.
    Acquaye JK; Tettey-Donkor D
    West Afr J Med; 2000; 19(4):239-41. PubMed ID: 11391831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
    Baur P; Roelcke D
    Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The usefulness of determining ALT in the detection of anti-HVC-positive cases among blood donors].
    Suárez A; Linares A; San Román FS; Rodrigo L
    Med Clin (Barc); 1993 May; 101(1):38. PubMed ID: 8391100
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients.
    Chauveau P; Courouce AM; Lemarec N; Naret C; Poignet JL; Girault A; Ramdame M; Delons S
    Kidney Int Suppl; 1993 Jun; 41():S149-52. PubMed ID: 7686591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide.
    Okamoto H; Munekata E; Tsuda F; Takahashi K; Yotsumoto S; Tanaka T; Tachibana K; Akahane Y; Sugai Y; Miyakawa Y
    Jpn J Exp Med; 1990 Aug; 60(4):223-33. PubMed ID: 1963454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-HCV in patients without risk factors for hepatitis C. Prospective study in 200 patients].
    Albornoz A; Esaa R; Rodríguez de Leon L; Mujica C
    G E N; 1993; 47(3):136-8. PubMed ID: 7509301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.